Voll, Reinhard E.

Immunosuppressive effects of apoptotic cells

Voll, R. E., Herrmann, M., Roth, E. A., Stach, C., Kalden, J. R., & Girkontaite, I. (1997) · Nature

Phagocytosis and Immune RegulationImmune Response and Inflammation

Cited by 1,787

Phosphorylation of NF-κB p65 by PKA Stimulates Transcriptional Activity by Promoting a Novel Bivalent Interaction with the Coactivator CBP/p300

Zhong, H., Voll, R. E., & Ghosh, S. (1998) · Molecular Cell

NF-κB Signaling PathwaysSignaling Pathways in Disease

Cited by 1,210

Release of High Mobility Group Box 1 by Dendritic Cells Controls T Cell Activation via the Receptor for Advanced Glycation End Products

Dumitriu, I. E., Baruah, P., Valentinis, B., Voll, R. E., Herrmann, M., Nawroth, P. P., Arnold, B., Bianchi, M. E., Manfredi, A. A., & Rovere-Querini, P. (2005) · The Journal of Immunology

Advanced Glycation End Products researchImmune Response and Inflammation

Cited by 503

Clearance deficiency and systemic lupus erythematosus (SLE)

Gaipl, U. S., Munoz, L. E., Grossmayer, G., Lauber, K., Franz, S., Sarter, K., Voll, R. E., Winkler, T., Kuhn, A., Kalden, J., et al. (2007) · Journal of Autoimmunity

Systemic Lupus Erythematosus ResearchPhagocytosis and Immune Regulation

Cited by 277

Increased bone density and resistance to ovariectomy-induced bone loss in FoxP3-transgenic mice based on impaired osteoclast differentiation

Zaiss, M. M., Sarter, K., Hess, A., Engelke, K., Böhm, C., Nimmerjahn, F., Voll, R., Schett, G., & David, J. (2010) · Arthritis & Rheumatism

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 122

Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases

Hasseli, R., Mueller-Ladner, U., Hoyer, B. F., Krause, A., Lorenz, H.-M., Pfeil, A., Richter, J., Schäfer, M., Schmeiser, T., Strangfeld, A., et al. (2021) · RMD Open

COVID-19 Clinical Research StudiesRheumatoid Arthritis Research and Therapies

Cited by 117

Cooperation between C1q and DNase I in the clearance of necrotic cell–derived chromatin

Gaipl, U. S., Beyer, T. D., Heyder, P., Kuenkele, S., Böttcher, A., Voll, R. E., Kalden, J. R., & Herrmann, M. (2004) · Arthritis & Rheumatism

Systemic Lupus Erythematosus ResearchPhagocytosis and Immune Regulation

Cited by 110

Secondary Antibody Deficiency in Glucocorticoid Therapy Clearly Differs from Primary Antibody Deficiency

Wirsum, C., Glaser, C., Gutenberger, S., Keller, B., Unger, S., Voll, R. E., Vach, W., Ness, T., & Warnatz, K. (2016) · Journal of Clinical Immunology

Immunodeficiency and Autoimmune DisordersAdrenal Hormones and Disorders

Cited by 64

Amplification of autoimmune organ damage by NKp46-activated ILC1s

Biniaris-Georgallis, S.-I., Aschman, T., Stergioula, K., Schreiber, F., Jafari, V., Taranko, A., Karmalkar, T., Kasapi, A., Lenac Rovis, T., Jelencic, V., et al. (2024) · Nature

Systemic Lupus Erythematosus ResearchIL-33, ST2, and ILC Pathways

Cited by 34